OCT Angiography in Primary Eye Care

Similar documents
ZEISS AngioPlex OCT Angiography. Clinical Case Reports

Incorporating OCT Angiography Into Patient Care

Introducing ANGIOVUE ESSENTIAL. Built on the Avanti Widefield OCT Platform. OCT Angiography for Primary Eye Care

The Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis

Visualize. Analyze. Personalize. OCT + OCTA

Dr/ Marwa Abdellah EOS /16/2018. Dr/ Marwa Abdellah EOS When do you ask Fluorescein angiography for optic disc diseases???

ATLAS OF OCT. Retinal Anatomy in Health & Pathology by Neal A. Adams, MD. Provided to you by:

OCT Interpretation in Retinal Disease

PART 1: GENERAL RETINAL ANATOMY

OCT Angiography. SriniVas Sadda, MD

Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema

Visualize. Analyze. Personalize. OCT + OCTA. with

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE RETINA AND OPTIC NERVE. Lindsay B. Howse, OD

OCT Angiography The Next Frontier

Ganglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD

Swept-Source OCT Angiography: SS OCT Angio TM

CHAPTER 8 EVALUATION OF FUNDUS IMAGE ANALYSIS SYSTEM

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

Leo Semes, OD, FAAO UAB Optometry

Posterior Segment Update

EyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion

Disease-Specific Fluorescein Angiography

Angio-OCT. Degenerazione Maculare Legata all Eta. Giuseppe Querques

Fluorescein Angiography

Spontaneous Large Serous Retinal Pigment Epithelial Tear

Simply the best OCT & OCTA image quality.

ZEISS AngioPlex OCT Angiography Overview ZEISS OCT Angiography

Disclosures. Definitions. Goals. Imaging and glaucoma 3/22/2016

OCT-Angiography Clinical Cases. OCT-Angiography Clinical Cases

10/17/2017. FDA Approved. Zeiss AngioPlex TM Optovue AngioVue TM

Mark Dunbar: Disclosure

What You Should Know About Acute Macular Neuroretinopathy

EyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy. George Bresnick MD MPA Jorge Cuadros OD PhD

SOUTH-EAST EUROPEAN JOURNAL of OPHTHALMOLOGY 2015; 1 (1) 34 40


OCT Angiography. Financial Disclosures: Pre-Test: Which one is Correct?

Diagnosis in AMD. Managing your AMD Patients

evaluation of vitreoretinal adhesions in exudative AMD using optical coherence tomography

The Human Eye. Cornea Iris. Pupil. Lens. Retina

ANSWERING THE WHY? Clinicians discuss the latest imaging technologies for retina practice BY PETER K. KAISER, MD

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015

OCT Angiography: An Upcoming Tool for Diagnosis and Treatment of Retinal Vascular Diseases

Clinical Study Optical Coherence Tomography Angiography in Retinal Vascular Diseases and Choroidal Neovascularization

Will OCT-Angiography replace FA?

Building The Retina Company

Do You See What I See!!! Shane R. Kannarr, OD

Moving forward with a different perspective

Diabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?

DIABETIC RETINOPATHY

HHS Public Access Author manuscript Ophthalmic Surg Lasers Imaging Retina. Author manuscript; available in PMC 2016 January 14.

DOME SHAPED MACULOPATHY. Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος

FA vs. OCTA? The status of OCTA, today. Fukuoka, JSOS 2016 Gerd Klose. Korobelnik J Fr Ophthalmol (2015)

Acquired vitelliform detachment in patients with subretinal drusenoid deposits (reticular pseudodrusen)

Diabetic Retinopathy A Presentation for the Public

OCT Interpretation. Financial Disclosure. Jay M. Haynie, OD, FAAO. OCT Image Layers 7/21/2014

Year 2 MBChB Clinical Skills Session Ophthalmoscopy. Reviewed & ratified by: Mr M Batterbury Consultant Ophthalmologist

11/29/2016 MACULAR MALADIES: TYPICAL & ATYPICAL CASES

Retinal Complications of Obstructive Sleep Apnea A Growing Concern!

Fundus Autofluorescence. Jonathan A. Micieli, MD Valérie Biousse, MD

Widefield Retinal Imaging with Auto Fluorescence Technology in the Optometric Practice

Cirrus TM HD-OCT. Details defi ne your decisions

November Volume 35 - Issue 11

Diabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012

Yasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD

Convergence in. Introduction. Case Report: Dr. Piyali SenM.B.B.S, Dr. Abhipsha Saha M.B.B.S, Dr. Anuradha Chandra M.S,FAICO

Central venous occlusion

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

IN NICU OCT UTILIZES A CONCEPT KNOWN AS INTERFEROMETRY APPLICATIONS FOR OCT THE PRIMARY USE IN THE EYE - RETINA

Photocoagulation of disciform macular lesions

OCT Fundal Angiography Initial Experience The new era in Medical Retina Imaging Based on Cirrus 5000 AngioPlex 2016 Model Sheena George & Nicholas

OCT Assessment of the Vitreoretinal Relationship in CSME

OCT Image Analysis System for Grading and Diagnosis of Retinal Diseases and its Integration in i-hospital

Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

Clinically Significant Macular Edema (CSME)

Advances in OCT Murray Fingeret, OD

ZEISS AngioPlex OCT Angiography Making the revolutionary, routine.

Misdiagnosed Vogt-Koyanagi-Harada (VKH) disease and atypical central serous chorioretinopathy (CSC)

Funduscopic Interpretation Understanding the Fundus: is that normal?

af Diagnostic Atlas A Retinal Reference Guide Building The Retina Company

Marcus Gonzales, OD, FAAO Cedar Springs Eye Clinic

Non-arteritic anterior ischemic optic neuropathy (NAION) with segmental optic disc edema. Jonathan A. Micieli, MD Valérie Biousse, MD

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

CENTRAL SEROUS CHORIORETINOPATHY (CSC) IS

A COMPLETE GUIDE TO THE CLARUS 500 ULTRA-WIDEFIELD RETINAL CAMERA

Outline. Preventing & Treating Diabetes Related Blindness. Eye Care Center Doctors. Justin Kanoff, MD. Eye Care Center of Northern Colorado

8/6/17. Disclosures Aerie Pharmaceuticals Alcon BioTissue Diopsys Optovue Shire

Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.

Automated segmentation and analysis of layers and structures of human posterior eye

Five Things You re Missing with Your Fundus Camera

Retinal pigment epithelial detachments in the elderly:

In 1990 our group first described reticular pseudodrusen as a. Choroidal Changes Associated with Reticular Pseudodrusen. Retina

Clinical Trial Endpoints for Macular Diseases

Title: OCT Analysis Workshop: Interpretation of OCT printouts

Ocular imaging in acquired retinopathy with multiple myeloma

Deeper visualizations for intervening with confidence.

Course # Getting to Know Your OCT

Cirrus TM HD-OCT. Details define your decisions

Key words: Choroidal neovascularisation, Laser coagulation, Retinal imaging

Transcription:

OCT Angiography in Primary Eye Care An Image Interpretation Primer Julie Rodman, OD, MS, FAAO and Nadia Waheed, MD, MPH

Table of Contents Diabetic Retinopathy 3-6 Choroidal Neovascularization 7-9 Central Serous Chorioretinopathy 10-11 Pigment Epithelial Detachment Case 12 1 2

DIABETIC RETINOPATHY Diabetic Retinopathy Case 1 Images courtesy of Julie Rodman, OD Diabetic Retinopathy Case 2 Images courtesy of Dan Esmaili, MD DIABETIC RETINOPATHY In this case, the color fundus photograph shows hard exudates inferonasal to the fovea (yellow arrow). Although there is no clear macular edema on the OCT B-scan, it shows hyper-reflective spots indicative of the hard exudates and also some structural changes and irregularity in the inner retina. These findings indicate that edema, possibly subclinical, may have been present previously. The color fundus photograph in this case indicates background diabetic retinopathy. On the OCTA images, capillary dropout (white arrows) is seen in both the superficial capillary plexus and the deep capillary plexus and it is distributed in both the superior and inferior macula. Pruning of the vasculature (yellow arrows), microaneurysms (blue arrow), and enlargement of the foveal avascular zone are also seen. In addition, the OCT B-scan shows intraretinal cystic changes that are indicative of early macular edema. Of the four automatically generated OCTA segmentation maps provided in the overview report, the two of most interest for evaluating diabetic eye disease are the slabs showing the superficial capillary plexus and the deep capillary plexus. Capillary dropout (white arrow), vascular remodeling (orange arrow) around the foveal avascular zone, and numerous small microaneurysms (blue arrow) are seen in the superficial and deep capillary plexus and appear to be correlated to the areas of hard exudates. This patient should be referred to a retina specialist for determination of when treatment should be initiated. Given the hard exudates and the ischemic changes detected by OCTA, this patient is at increased risk for developing diabetic macular edema and should be monitored closely. Examination and OCT scans should be repeated in 3-4 months with a low threshold for referral if the signs worsen. Superficial Plexus Deep Plexus Outer Retina Choriocapillaris Superficial Plexus Deep Capillary Plexus Outer Retina Choriocapillaris 3 4

DIABETIC RETINOPATHY Diabetic Retinopathy Case 3 Images courtesy of Dan Esmaili, MD Diabetic Retinopathy Case 4 Images courtesy of Dan Esmaili, MD DIABETIC RETINOPATHY Based on the intraretinal hemorrhages and cotton wool spots appearing on the color fundus photograph, this patient has moderate to severe diabetic retinopathy and ischemia. The hard exudates, microaneurysms, and cotton wool spots on this color fundus photograph indicate diabetic retinopathy. In addition, the appearance of the optic nerve suggests the possible presence of early pre-retinal neovascularization of the disc (NVD), which would signify proliferative diabetic retinopathy. The OCTA images of the superficial capillary plexus and the deep capillary plexus reveal severe ischemia and swaths of capillary dropout (white arrows), especially on the temporal aspect of the fovea. Interestingly, the OCT B-scan shows not only some mild intraretinal cystic changes indicative of early macular edema but also, on the temporal portion of the scan, loss of layer integrity in the inner retina and thinning of the retina associated with the areas that have profound ischemia. Recent research suggests that areas of capillary loss detected on OCTA are associated with atrophic loss of integrity of the inner retina, similar to the association previously shown to be present on fluorescein angiogram. OCTA can be of enormous help when NVD is a concern. In this case, while OCT B-scans over the optic disc reveal the presence of fibrous tissue anterior to the disc extending into the vitreous, OCTA imaging of the region (Angio Disc) with vitreous segmentation confirms that the tissue is vascularized. Note how NVD is obvious on OCTA (white arrow) but could have been missed easily on the fundus photograph. This patient has proliferative diabetic retinopathy and should be referred to a retina specialist. This patient should be examined carefully for retinal neovascularization. While immediate intervention may not necessarily be warranted, referral to a retina specialist for fluorescein angiography, preferably widefield, and closer follow-up of the macular edema is prudent. Fluorescein angiography would be useful in detecting retinal neovascularization, and, to a lesser extent, peripheral ischemia, which is likely to be present based on the central ischemia seen on OCTA. Superficial Plexus Deep Plexus Outer Retina Choriocapillaris Flow Overlay OCT of Optic Nerve OCT B-scan of Optic Nerve 5 6

Choroidal Neovascularization Case 1 Images courtesy of Julie Rodman, OD CHOROIDAL NEOVASCULARIZATION In this case, the color fundus photograph shows pigment changes in the macula, and the OCT B-scan reveals a low-lying pigment epithelial detachment but no subretinal fluid. Of the four automatically generated OCTA segmentation maps provided in the overview report, the two of most interest for evaluating choroidal neovascularization (CNV) are the slabs showing the avascular outer retina zone and the choriocapillaris. In this case, there appears to be abnormal vasculature/cnv seen on the outer retina and choriocapillaris slabs (white arrows). However, clinicians must be aware that projection artifact from the superficial retinal vasculature, or larger choroidal vessels that have been displaced into an area of atrophy can masquerade as CNV. Projection artifact is an effect that occurs when the OCT signal passes through moving blood, reflects off underlying tissue, and is erroneously interpreted as blood flow. The result is the appearance of vessels that are actually located in an overlying layer. Thus retinal vessels projected onto the outer retina can mimic the appearance of CNV. CHOROIDAL NEOVASCULARIZATION Geographic atrophy causes loss of choriocapillaris and allows larger choroidal blood vessels to migrate into the space ordinarily occupied by the choriocapillaris. These larger choroidal vessels can also give the appearance of CNV. To rule out projection artifact, it is necessary to ensure the segmentation lines don t intersect with the top of a retinal pigment epithelial detachment, which would result in the normal retinal vasculature appearing to be in the outer retina. In addition, the overlying retinal vascular patterns can be compared to the vasculature in the presumed CNV to determine whether they match. To determine whether larger choroidal vessels displaced into an area of atrophy are masquerading as CNV, evaluate the OCT B-scan over the area of interest as well as the structural en face scan. On the B-scan, atrophy is seen as loss of outer retina and retinal pigment epithelium that allows hyper-transmission of light into the choroid. This also appears as a bright area on the structural en face scan at the level of the choriocapillaris and below. OCTA Outer Retina OCTA Choriocapillaris In the case shown here, no confounding projection artifacts or atrophy appear on the B-scan or en face image. Therefore, true CNV is most likely present. Also, as previously mentioned, no subretinal fluid appears on the OCT B-scan, which indicates that the CNV may be subclinical. It s important in this situation to scroll through all of the OCT B-scans to determine whether any fluid is present. If fluid is present, the patient should be seen by a retina specialist within a few days. If no fluid is present, the patient should be referred and seen within a few weeks. The retinal physician will most likely monitor but not treat asymptomatic CNV. Structural En Face OCT 7 8

Choroidal Neovascularization Case 2 Central Serous Chorioretinopathy Case 1 Images courtesy of Dan Esmaili, MD Images courtesy of Julie Rodman, OD CHOROIDAL NEOVASCULARIZATION The color fundus photograph in this patient illustrates retinal pigment epithelium changes characteristic of agerelated macular degeneration (yellow arrow). While the OCT B-scan indicates an absence of subretinal fluid (white arrow), CNV appears to be present on both the OCTA outer retina and choriocapillaris slabs (blue arrows). Note how the choriocapillaris slab appears before the automatic removal of projection artifact (choriocapillaris image bottom left). The vessels of the superficial layer are projected into the choriocapillaris layer (green arrows). On the flow overlay image, the green arrow shows some flow beneath a shallow PED that represents the CNV. As with the previous patient, look carefully for any subretinal fluid, and refer to a retinal specialist. In this patient with central serous chorioretinopathy (CSCR), the retinal pigment epithelium atrophy and area of subretinal fluid with underlying hyper-transmission apparent on the OCT B-scan (yellow arrow) suggest chronicity. OCTA is an ideal modality for determining whether CNV is present in cases of CSCR. Here, larger vessels are seen on the OCTA choriocapillaris slab (orange arrow). However, the corresponding area of hyper-transmission on the OCT B-scan and the structural en face scan (yellow arrow) indicates that CNV may not be present. Rather, larger choroidal vessels, which likely migrated anteriorly due to choriocapillaris atrophy accompanying the retinal pigment epithelium atrophy, are visible. Therefore, in this case of chronic CSCR with likely no CNV, the patient should be referred to a retinal specialist for further evaluation and possible fluorescein or indocyanine green angiography to rule out CNV. CHOROIDAL NEOVASCULARIZATION Superficial Plexus Deep Plexus Outer Retina Choriocapillaris OCTA Choriocapillaris Structural En Face OCT OCT with Flow Overlay Choriocapillaris Before Projection Artifact Removal 9 10

Central Serous Chorioretinopathy Case 2 Pigment Epithelial Detachment Case 1 Images courtesy of David Sarraf, MD Images courtesy of Julie Rodman, OD The color fundus photograph below is indicative of subretinal fluid inferior to the fovea. The OCT B-scan reveals subretinal fluid and a shallow pigment epithelial detachment. The color fundus photograph in this case illustrates a few drusen and pigment mottling. The pigment loss, nasal to the fovea, may indicate an area of atrophy or a pigment epithelial detachment. On the OCTA outer retina slab, an abnormal vascular pattern appears (white arrows), raising the suspicion of CNV. Because the structural OCT en face image raises no suspicion of atrophy, the presence of CNV is likely. With the flow signal underlying the area of pigment epithelial detachment (yellow arrow), the OCT B-scan with flow overlay confirms the presence of type 1 CNV. A shallow pigment epithelial detachment is visible on the OCT B-scan (white arrow), but no subretinal fluid is apparent. However, CNV is apparent on the OCTA imaging slabs that represent the outer retina and choriocapillaris (yellow arrows). Again, in this situation, it becomes very important to scroll through all of the volumetric structural B-scans and evaluate for the presence of subretinal or intraretinal fluid. If fluid is present, it warrants an immediate referral. CENTRAL SEROUS CHORIORETINOPATHY This patient should be referred to a retina specialist and seen within a few days. Even if subretinal or intraretinal fluid is not present, the CNV confers a high risk of conversion to exudative AMD and should be monitored. The patient should be screened for CNV symptoms such as vision loss or metamorphopsia and referred to a retina specialist to be seen in 1-3 weeks. PIGMENT EPITHELIAL DETACHMENT OCT with Flow Overlay OCTA of Outer Retina and Choriocapillaris Structural En Face OCT Superficial Plexus Deep Plexus Outer Retina Choriocapillaris 11 12

Our vision is foresight 2800 Bayview Drive, Fremont, CA 94538 +1.510.623.8868 optovue.com 2018 Optovue, Inc. Optovue, AngioVue, AngioAnalytics and DualTrac are trademarks or registered trademarks of Optovue, Inc. All rights reserved. Spectralis is a registered trademark of Heidelberg Engineering. 300-53310 Rev. A